Skip to content

13F-HR filed by Boxer Capital, LLC

Boxer Capital, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 33 holding rows worth $936,872,000.

Accession
0000950123-18-005733
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 33 entries on the cover page, a total value of $936,872,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $936,874,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVEXIS INC05366U100COM900,000$111,222,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR630,000$105,840,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM2,600,000$70,174,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock900,000$65,097,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM2,826,938$59,875,000thousands by filing date
MACROGENICS INC556099109COM2,200,000$55,352,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock1,350,000$54,068,000thousands by filing date
LOXO ONCOLOGY INC548862101COM400,000$46,148,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM1,372,510$42,136,000thousands by filing date
MEDICINES CO584688105COM1,250,000$41,175,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,966,051$36,863,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM2,712,986$35,242,000thousands by filing date
GTX INC DEL40052B207COM NEW1,590,000$28,223,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM660,000$24,453,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR1,020,000$23,531,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM250,000$22,925,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK5,140,000$18,196,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock844,789$15,840,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM3,186,000$13,923,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock312,000$13,753,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM747,500$10,525,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2267,500$7,966,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A325,000$6,666,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM2,125,000$5,780,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock750,000$5,625,000thousands by filing date
DERMIRA INC24983L104COM500,000$3,995,000thousands by filing date
BELLEROPHON THERAPEUTICS INC078771102COM1,857,143$3,863,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM350,000$2,296,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559903Cmn500,000$1,770,000thousands by filing datecall
NOVUS THERAPEUTICS INC67011N105COM324,383$1,635,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM100,000$1,423,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM1,697,802$1,222,000thousands by filing date
ONCONOVA THERAPEUTICS INC68232V116*W EXP 07/11/202241,644$72,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-18-005733this filing2018-05-15acceptance time not in the bulk data set